AstraZeneca PLC (AZN)

AstraZeneca Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,488	5,840	6,166	6,329	7,832
Short-Term Investments	166	-	64	53	42
Trading Asset Securities	-	20	14	16	161
Cash & Short-Term Investments	5,654	5,860	6,244	6,398	8,035
Cash Growth	-3.52%	-6.15%	-2.41%	-20.37%	29.22%
Accounts Receivable	12,972	8,407	7,212	6,031	3,806
Other Receivables	1,859	3,528	2,711	2,764	1,845
Receivables	14,831	11,935	9,923	8,795	5,651
Inventory	5,288	5,424	4,699	8,983	4,024
Prepaid Expenses	-	1,617	1,329	1,512	1,735
Restricted Cash	-	102	162	-	-
Other Current Assets	54	116	236	556	99
Total Current Assets	25,827	25,054	22,593	26,244	19,544
Property, Plant & Equipment	11,647	10,502	9,449	10,171	8,917
Long-Term Investments	1,900	1,777	1,142	1,262	1,192
Goodwill	21,025	20,048	19,820	19,997	11,845
Other Intangible Assets	37,177	38,089	39,307	42,387	20,947
Long-Term Deferred Tax Assets	5,347	4,718	3,263	4,330	3,438
Other Long-Term Assets	1,112	931	909	972	846
Total Assets	104,035	101,119	96,483	105,363	66,729
Accounts Payable	22,465	3,267	2,550	2,824	2,350
Accrued Expenses	-	15,743	13,427	12,358	9,689
Short-Term Debt	330	5,129	5,314	411	661
Current Portion of Long-Term Debt	2,057	989	960	2,248	1,566
Current Portion of Leases	339	271	228	233	192
Current Income Taxes Payable	1,406	1,584	896	916	1,127
Current Unearned Revenue	-	251	269	1,181	1,958
Other Current Liabilities	1,269	3,308	2,649	2,423	2,764
Total Current Liabilities	27,866	30,542	26,293	22,594	20,307
Long-Term Debt	26,621	22,403	23,908	29,717	19,804
Long-Term Leases	1,113	857	725	754	489
Long-Term Unearned Revenue	-	7	14	26	38
Long-Term Deferred Tax Liabilities	3,305	2,844	2,944	6,206	2,918
Other Long-Term Liabilities	2,929	3,780	4,373	4,325	4,333
Total Liabilities	63,164	61,953	59,425	66,076	51,091
Common Stock	388	388	387	387	328
Additional Paid-In Capital	35,226	35,188	35,155	35,126	7,971
Retained Earnings	3,160	4,516	3,120	3,644	6,442
Comprehensive Income & Other	2,012	-949	-1,625	111	881
Total Common Equity	40,786	39,143	37,037	39,268	15,622
Minority Interest	85	23	21	19	16
Shareholders' Equity	40,871	39,166	37,058	39,287	15,638
Total Liabilities & Equity	104,035	101,119	96,483	105,363	66,729
Total Debt	30,460	29,649	31,135	33,363	22,712
Net Cash (Debt)	-24,806	-23,789	-24,891	-26,965	-14,677
Net Cash Per Share	-15.87	-15.23	-15.96	-18.90	-11.18
Filing Date Shares Outstanding	1,550	1,550	1,550	1,549	1,313
Total Common Shares Outstanding	1,550	1,550	1,550	1,549	1,313
Working Capital	-2,039	-5,488	-3,700	3,650	-763
Book Value Per Share	26.31	25.25	23.90	25.34	11.90
Tangible Book Value	-17,416	-18,994	-22,090	-23,116	-17,170
Tangible Book Value Per Share	-11.24	-12.25	-14.25	-14.92	-13.08
Land	-	6,469	5,440	6,377	5,851
Machinery	-	8,704	7,556	7,903	7,738
Construction In Progress	-	2,045	2,653	2,728	2,478

Source: S&P Capital IQ. Standard template. Financial Sources.